Elizabeth Garner

3.4k total citations · 1 hit paper
55 papers, 2.3k citations indexed

About

Elizabeth Garner is a scholar working on Epidemiology, Obstetrics and Gynecology and Reproductive Medicine. According to data from OpenAlex, Elizabeth Garner has authored 55 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 14 papers in Obstetrics and Gynecology and 14 papers in Reproductive Medicine. Recurrent topics in Elizabeth Garner's work include Cervical Cancer and HPV Research (15 papers), Endometriosis Research and Treatment (12 papers) and Uterine Myomas and Treatments (11 papers). Elizabeth Garner is often cited by papers focused on Cervical Cancer and HPV Research (15 papers), Endometriosis Research and Treatment (12 papers) and Uterine Myomas and Treatments (11 papers). Elizabeth Garner collaborates with scholars based in United States, Australia and Belgium. Elizabeth Garner's co-authors include Richard M. Haupt, Ross S. Berkowitz, Scott Vuocolo, Edson Duarte Moreira, Heiko Jessen, Anna R. Giuliano, Joel M. Palefsky, David Radley, François Coutlée and Stephen E. Goldstone and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Elizabeth Garner

53 papers receiving 2.2k citations

Hit Papers

HPV Vaccine against Anal HPV Infection and Anal Intraepit... 2011 2026 2016 2021 2011 200 400 600

Peers

Elizabeth Garner
Jette Junge Denmark
Megan A. Clarke United States
Yin Ling Woo Malaysia
C. David Wrede Australia
A Perino Italy
Pamela J. Thompson United States
A Frega Italy
Elizabeth Garner
Citations per year, relative to Elizabeth Garner Elizabeth Garner (= 1×) peers Elmar A. Joura

Countries citing papers authored by Elizabeth Garner

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Garner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Garner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Garner more than expected).

Fields of papers citing papers by Elizabeth Garner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Garner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Garner. The network helps show where Elizabeth Garner may publish in the future.

Co-authorship network of co-authors of Elizabeth Garner

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Garner. A scholar is included among the top collaborators of Elizabeth Garner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Garner. Elizabeth Garner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asante, Bright Owusu, et al.. (2023). Access and Control of Resources and Participation in Rice-Breeding Activities among Men and Women Farmers in Southern Ghana. Sustainability. 15(9). 7069–7069. 8 indexed citations
2.
Donnez, Jacques, Hugh S. Taylor, Elizabeth A. Stewart, et al.. (2022). Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials. The Lancet. 400(10356). 896–907. 39 indexed citations
3.
Donnez, Jacques, Olivier Donnez, Elke Bestel, et al.. (2021). Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New ’Hit Hard First and then Maintain’ Regimen of Administration. Journal of Clinical Medicine. 10(24). 5794–5794. 16 indexed citations
4.
Donnez, Jacques, Olivier Donnez, Elke Bestel, et al.. (2021). Treatment of symptomatic uterine adenomyosis with linzagolix, an oral gonadotrophin-releasing hormone antagonist: a pilot study. Reproductive BioMedicine Online. 44(1). 200–203. 12 indexed citations
5.
Griesinger, Georg, Jacques Donnez, Andrew Humberstone, et al.. (2020). THE EFFECT OF THE ORAL OXYTOCIN ANTAGONIST, NOLASIBAN, ON PREGNANCY RATES IN WOMEN UNDERGOING EMBRYO TRANSFER FOLLOWING IVF. Fertility and Sterility. 114(3). e303–e303. 1 indexed citations
6.
Edelman, Alison, James Trussell, Abigail R.A. Aiken, et al.. (2017). The emerging role of obesity in short-acting hormonal contraceptive effectiveness. Contraception. 97(5). 371–377. 7 indexed citations
7.
Goldstone, Stephen E., Heiko Jessen, Joel M. Palefsky, et al.. (2013). Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males. Vaccine. 31(37). 3849–3855. 38 indexed citations
8.
Brown, Darron R., Suzanne M. Garland, Daron G. Ferris, et al.. (2011). The humoral response to Gardasil over four years as defined by Total IgG and competitive Luminex immunoassay. Human Vaccines. 7(2). 230–238. 90 indexed citations
9.
Moreira, Edson Duarte, Joel M. Palefsky, Anna R. Giuliano, et al.. (2011). Safety and reactogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 viral-like-particle vaccine in older adolescents and young adults. Human Vaccines. 7(7). 768–775. 27 indexed citations
10.
Gao, Zhijian, Xiaoyin Xu, Bruce A. McClane, et al.. (2010). C Terminus of Clostridium perfringens Enterotoxin Downregulates CLDN4 and Sensitizes Ovarian Cancer Cells to Taxol and Carboplatin. Clinical Cancer Research. 17(5). 1065–1074. 43 indexed citations
11.
Garner, Elizabeth. (2010). A Case Study: Lessons Learned From Human Papillomavirus Vaccine Development: Approval of a Vaccine for Use in Children and Young Adolescents for Prevention of an Adult Disease. JAIDS Journal of Acquired Immune Deficiency Syndromes. 54(Supplement 1). S50–S52. 4 indexed citations
13.
Ko, Emily, et al.. (2010). Use of multimedia as an educational tool to improve human papillomavirus vaccine acceptability—A pilot study. Gynecologic Oncology. 118(2). 103–107. 25 indexed citations
14.
Vardas, Eftyhia, Anna R. Giuliano, Joel M. Palefsky, et al.. (2010). External Genital Human Papillomavirus Prevalence and Associated Factors Among Heterosexual Men on 5 Continents. The Journal of Infectious Diseases. 203(1). 58–65. 86 indexed citations
15.
Welch, William R., et al.. (2007). Stratifin expression in epithelial ovarian cancer: the role of methylation in vitro and in vivo. Cancer Research. 67. 1057–1057. 1 indexed citations
16.
Garner, Elizabeth, et al.. (2007). Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma. Gynecologic Oncology. 106(2). 311–317. 55 indexed citations
17.
Garner, Elizabeth, Donald P. Goldstein, Colleen M. Feltmate, & Ross S. Berkowitz. (2007). Gestational Trophoblastic Disease. Clinical Obstetrics & Gynecology. 50(1). 112–122. 75 indexed citations
19.
Quaas, Alexander, et al.. (2007). The Superinfection of a Dermoid Cyst. Infectious Diseases in Obstetrics and Gynecology. 2007. 1–2. 4 indexed citations
20.
Lacour, Robin A., Elizabeth Garner, Kelly L. Molpus, Raheela Ashfaq, & John O. Schorge. (2005). Management of cervical adenocarcinoma in situ during pregnancy. American Journal of Obstetrics and Gynecology. 192(5). 1449–1451. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026